Tumor necrosis factor-α stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: Down-regulation by cAMP  by Chen, Yung-Ming et al.
Kidney International, Vol. 63 (2003), pp. 474–486
Tumor necrosis factor- stimulates fractalkine production by
mesangial cells and regulates monocyte transmigration:
Down-regulation by cAMP
YUNG-MING CHEN, SHUEI-LIONG LIN, CHING-WEN CHEN, WEN-CHIH CHIANG, TUN-JUN TSAI,
and BOR-SHEN HSIEH
Department of Medicine, National Taiwan University Hospital, and Department of Pharmacology, College of Medicine,
National Taiwan University, Taipei, Taiwan
pho-c-Jun levels, whereas only calphostin C inhibited TNF-–Tumor necrosis factor- stimulates fractalkine production by
activated phosphorylation of PKC/. The incubation of MCsmesangial cells and regulates monocyte transmigration: Down-
with MG132, a NF-B inhibitor, abolished TNF-–induced deg-regulation by cAMP.
radation of inhibitory protein of NF-B (I-B), nuclear trans-Background. Fractalkine is a CX3C chemokine for mono-
location of NF-B, and fractalkine expression, without affect-nuclear cells that has been implicated in the recruitment and ac-
ing phospho-c-Jun levels. In contrast, curcumin, an activatingcumulation of monocytes seen in glomerular diseases. We inves-
protein (AP)-1 inhibitor, attenuated TNF-–stimulated phos-tigated the mechanisms by which tumor necrosis factor (TNF)-
pho-c-Jun levels and fractalkine expression without discerniblestimulates mesangial cell (MC) fractalkine expression, and the
effects on TNF-–induced degradation of I-B or NF-B nu-effects of MC-derived fractalkine on monocyte transmigration.
clear translocation. Neither PD 98059 nor calphostin C affectedMethods. Cultured rat MCs were incubated with TNF-,
with or without pretreatment with pharmacologic inhibitors of TNF-–induced degradation of I-B or NF-B nuclear trans-
protein kinases or transcriptional factors downstream to TNF-. location. Additional experiments examining the role of cAMP
Fractalkine mRNA and protein were analyzed by Northern and on MC fractalkine expression showed that the incubation of
Western blotting. Translocation of nuclear factor (NF)-B was MCs with TNF- and either db-cAMP or forskolin attenuated
evaluated by immunocytochemical staining. Monocyte trans- TNF-–stimulated fractalkine mRNA and protein expression,
migration was determined by in vitro chemotaxis assay. preceded by attenuation of TNF-–activated phosphorylation
Results. TNF- stimulated MC fractalkine mRNA as well as of p42/44 MAPK, and c-Jun, but not phosphorylation of PKC/
cell-bound and soluble protein expression in a dose- and time- or nuclear translocation of NF-B.
dependent manner. The soluble fractalkine was shed from the Conclusion. The present data indicate that TNF- activation
cell-bound form via metalloproteinase-dependent cleavage, of PKC/, p42/44 MAPK, c-Jun/AP-1, and p65/NF-B are in-
and mediated in part TNF-–induced monocyte transmigration volved in TNF-–stimulated MC fractalkine expression, with the
in vitro. The incubation of MCs with calphostin C [a selective soluble fractalkine mediating in part the TNF-–induced mono-
inhibitor of protein kinase C (PKC)] or PD98059 [a selective cyte transmigration in vitro. Uncoupling of p42/44 MAPK or
inhibitor of p42/44 mitogen-activated protein kinase (MAPK) c-Jun/AP-1 signals may contribute to cAMP inhibition of MC
kinase] attenuated TNF-–stimulated fractalkine mRNA and fractalkine expression activated by TNF-.
protein expression. Coincubation of MCs with calphostin C and
PD98059 resulted in a synergistic inhibition of TNF-–stimulated
fractalkine mRNA and protein expression. Incubation of MCs
Infiltration and accumulation of monocytes/macro-with phorbol myristate acetate (PMA) for four hours resulted
in an increase in fractalkine mRNA expression that could be phages within the glomerular mesangium are prominent
suppressed by calphostin C or depletion of PKC by pretreatment pathobiologic features of human and experimental glo-
with PMA for 24 hours. Further, activation of PKC-depleted
merular diseases. The mechanisms underlying monocyteMCs with TNF- stimulated fractalkine mRNA expression that
infiltration involve a series of complex interactions be-could be blocked by calphostin C. PD 98059, but not calphostin
C, inhibited TNF-–activated phospho-p42/44 MAPK and phos- tween circulating leukocytes and resident glomerular
cells. These interactions are intensified by the enhanced
expression of adhesion molecules and chemokines by
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resident glomerular cells [1–3]. A key chemokine knowntalkine, crescentic glomerulonephritis, adhesion molecule, mesengial
cells, cytokines, migration. to capture and direct migration of monocytes to sites
of inflammation is fractalkine [4]. It is a novel CX3CReceived for publication February 4, 2002
chemokine whose expression is regulated primarily byand in revised form July 12, 2002
Accepted for publication September 24, 2002 proinflammatory cytokines such as tumor necrosis factor
(TNF)- and interleukin (IL)-1 [4–6]. Unlike the CC or 2003 by the International Society of Nephrology
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CXC chemokines, which are secreted peptides by profes- METHODS
sional immune cells, fractalkine is presented on the sur- Reagents
face of activated endothelial cells in the vasculature via
RPMI 1640 media, fetal calf serum (FCS), and otherits C-terminal transmembrane domain [4]. This cell mem-
tissue culture reagents were obtained from Gibco BRLbrane-bound fractalkine acts as an adhesive molecule and
(Rockville, MD, USA). Culture flasks and plates wereforms firm adhesion with circulating mononuclear cells
purchased from Costa Corning (Cambridge, MA, USA).expressing its cognate receptor, CX3CR1 [7, 8]. When Dibutyryl(db)-cAMP and goat IgG were purchased fromcleaved at a conserved motif proximal to the membrane
Sigma Chemical Co. (St. Louis, MO, USA). Forskolin, cal-by metalloproteinases, fractalkine can be shed and be-
phostin C, phorbol myristate acetate (PMA), N-[2-bromo-comes a soluble chemoattractant [4, 9, 10]. Recent stud-
cinnamyl (amino)ethyl]-5-isoquinolinesulfonamide (H-89),ies suggest potential pathophysiologic roles for fractal-
PD98059, SB203580, wortmannin, curcumin, MG132, quer-kine in rat and human crescentic glomerulonephritis,
cetin, tosyl-phe-chloromethylketone (TPCK), pyrrolidinemouse cardiac allograft rejection, and human atheroscle-
dithiocarbamate (PDTC), and GM 6001 were obtainedrotic coronary artery disease [11–14].
from Calbiochem (La Jolla, CA, USA). Recombinant ratWhile fractalkine has been shown to be produced by
TNF-, mouse fractalkine, and goat anti-rat fractalkinenon-endothelial cells, which include neurons and astro-
were obtained from R & D Systems (Minneapolis, MN,cytes in the central nervous system [5, 15, 16], dendritic
USA). Mouse anti-phospho-p42/44 MAPK was obtainedcells within the tonsil and skin [6, 17], and epithelial cells
from New England BioLab (Beverly, MA, USA). Mousein the gut [18], information is limited with regards to its
anti-phospho-c-Jun, anti--actin, and rabbit anti-phos-expression by renal cells. The mesangial cells (MCs) are
pho-PKC/, anti-p65/NF-B, anti-inhibitory protein ofsmooth muscle-like cells within the glomerulus that play
NF-B (I-B) were purchased from Santa Cruz Bio-a key role in maintaining glomerular capillary integrity
technologies (Santa Cruz, CA, USA). All chemicals usedand regulating glomerular filtration area [19]. In addi-
for total RNA isolation, Northern and Western blot anal-tion, MCs have been implicated in the recruitment of
yses were of molecular grade and were obtained fromcirculating leukocytes via, at least in part, synthesis of
Sigma or Roche Molecular Biochemicals (Mannheim,distinct sets of chemokines [20–24]. These distinct sets
Germany) unless otherwise specified.of MC-derived chemokines may facilitate extravasation
and infiltration of leukocytes into the affected glomeruli,
Cell cultures
and augment the extent and severity of inflammation
Primary culturing of rat MCs was performed as de-[25, 26]. TNF- is a multifunctional cytokine that has
scribed previously [32]. Cells were characterized as MCsbeen reported to induce the expression of an array of
on the basis of the presence of -smooth muscle actinCC and CXC chemokine genes and their products in a
staining with the avidin-biotin-peroxidase method, usingvariety of cell types including the MCs [24]. Recently,
diaminobenzidine as the chromogen. Rat MCs between 10we found that cultured rat MCs produced fractalkine in
and 20 passages were used and grown in RPMI 1640 mediaresponse to TNF-. In cultured endothelial cells, Garcia
containing 10% FCS and 30 g/mL of insulin. Murineet al have shown that TNF- induces fractalkine expres-
macrophages (J774.A1) were obtained from the Ameri-sion via a nuclear factor (NF)-B–dependent mechanism
can Type Culture Collection (Rockville, MD, USA), and[27]. However, they did not present additional intracellu-
grown in Dulbecco’s modified Eagle’s medium (DMEM)lar mechanisms that could be responsible for fractalkine
according to the supplier’s instructions.expression given the complexity of signaling pathways
Experiments were performed to determine the regula-elicited by TNF- [28–31]. Our present study investi-
tory role of various protein kinases, NF-B, AP-1 andgated the mechanisms involved in TNF-–stimulated
cAMP on TNF-–stimulated fractalkine expression byfractalkine expression by MCs and the potential chemo-
MCs. The effects of cAMP-dependent protein kinasetactic effects of MC-derived fractalkine.
(PKA), PKC, phosphatidylinositol 3-kinase (PI 3-K),This report shows that TNF- stimulates both cell-
p42/44 MAPK, and p38 MAPK on MC gene expressionbound and cleaved soluble fractalkine production by
were evaluated by incubating cells with selective proteinMCs, and the soluble form mediates at least partially
kinase inhibitors. Cells were first grown in RPMI 1640the TNF-–induced monocyte transmigration in vitro.
containing 10% FCS until reaching 90% confluency, fol-TNF- activation of protein kinase C (PKC), p42/44 mi-
lowed by RPMI 1640  0.5% FCS for 24 hours beforetogen-activated protein kinase (MAPK), activating pro-
pre-incubating with either a specific PKC inhibitor cal-tein (AP)-1, and NF-B are involved in TNF-–stimu-
phostin C (400 nmol/L for 1 h), a selective PKA inhibitorlated MC fractalkine expression, and uncoupling of
H-89 (2 mol/L for 30 min), a p42/44 MAPK kinase in-p42/44 MAPK or c-Jun/AP-1 signals may contribute to
hibitor PD98059 (40 mol/L for 30 min), a p38 MAPKcyclic AMP (cAMP) inhibition of MC fractalkine pro-
duction stimulated by TNF-. inhibitor SB203580 (40 mol/L for 30 min), or a PI 3-K in-
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hibitor wortmannin (0.5 mol/L for 30 min). After pre- Northern blot analysis
incubation, cells were stimulated with TNF- (5 ng/mL) Ten micrograms of total RNA were electrophoresed
for four or 24 hours at 37C before harvesting for RNA on formaldehyde-denatured 1% agarose gels and subse-
or protein extraction. Further experiments were conducted quently transferred to nylon membranes according to
to examine the role of AP-1 and NF-B on TNF-–stim- standard protocols [34]. To synthesize fractalkine ribo-
ulated fractalkine expression by MCs. The AP-1 inhibi- probe, the cDNA fragment of rat fractalkine was first
tor curcumin (20 to 40mol/L) and various NF-B inhib- amplified by RT-PCR from glomerular RNA of nephritic
itors (MG132 10 mol/L, quercetin 50 mol/L, TPCK rats, using the upstream primer, 5	-attttccaagacagaggacc-3	,
25 mol/L, and PDTC 50 mol/L) were preincubated and downstream primer, 5	-gaagagtagaccaagaaagg-3	 [5].
with cells for 1.5 hours (curcumin, MG132 and quercetin) The digoxigenin-conjugated fractalkine riboprobe was
then synthesized by in vitro transcription as describedand one hour (for TPCK and PDTC). After preincuba-
previously [35]. After hybridization, the blots were de-tion, cells were stimulated with TNF- 5 ng/mL for four
veloped using CSPD (Roche) as the substrate for alka-or 24 hours at 37C before harvesting for RNA or protein
line phosphatase. The intensity of the signal was thenextraction. Additional studies were designed to examine
quantified with computerized densitometry, and normal-the role of cAMP-mediated signaling pathways in MC
ized against the signal of glyceraldehyde-3-phosphatefractalkine expression. Cyclic AMP-elevating substances,
dehydrogenase (GAPDH) messages.including db-cAMP (a cell permeable cAMP analog)
and forskolin (an adenylate cyclase activator) were first
Western blot analysisincubated with MCs for four hours at 37C to determine
To detect cell-bound fractalkine protein, MCs werethe role of cAMP on basal MC fractalkine mRNA ex-
washed and lysed in RIPA buffer containing 1% IGEPALpression. Further experiments were performed to exam-
CA-630 and 0.25% deoxycholate (Sigma). Forty micro-ine the role of cAMP on TNF-–stimulated MC fractal-
grams of cell lysate were heated at 100C for 10 minutes,kine expression. Cells were preincubated with db-cAMP
applied to 7.5% (for fractalkine) or 10% (for phospho-(0.2 to 2 mmol/L) for 15 minutes or forskolin (25 to 100
p42/44 MAPK, phospho-PKC/, phospho-c-Jun, IB,mol/L) for 45 minutes, followed by TNF- (5 ng/mL)
and -actin) sodium dodecyl sulfate (SDS)-polyacryl-stimulation for four or 24 hours at 37C before harvesting
amide gels, and electrophoresed. For detection of solublefor RNA or protein extraction.
fractalkine in the conditioned medium of TNF-–acti-
vated MCs, media were concentrated with Centricon-RT-PCR
10 (Millipore, Bedford, MA, USA), and 50 g of pro-Total RNA was extracted by the acid guanidinium thio-
tein were electrophoresed on 7.5% SDS-polyacrylamide
cyanate phenol chloroform method [33]. Five micrograms
gels. A prestained marker was also electrophoresed as
of the RNA were reverse-transcribed (RT) to first strand
a molecular weight marker. After electrophoresis, pro-
cDNA using MMLV reverse transcriptase according to teins were transferred onto a polyvinylidine difluoride
the manufacturer’s instructions (Promega). Polymerase (PVDF) membrane (Millipore) using a transblot cham-
chain reaction (PCR) for rat and mouse CX3CR1 (recep- ber with Tris buffer. Western blots were incubated at 4C
tor for fractalkine) mRNA was performed by adding 3 L overnight with primary antibodies. The next morning,
(150 ng) of the first-strand cDNA in a total of 10 L membranes were washed with PBS/Tween-20 at room
containing 50 mmol/L Tris, 0.25 g/mL bovine serum temperature for 40 minutes, and incubated with peroxi-
albumin (BSA), 1 mmol/L MgCl2, 200 mol/L dNTPs, dase-conjugated second antibodies at room temperature
33 pmoles of each primer, and 0.5 U DNA polymerase. for one hour. After washing, the membranes were incu-
The primers for CX3CR1, 5	-gctggaaggcataattacat-3	 (up- bated with Renaissance (NEN Life Science, Boston,
stream), and 5	-ttgggactcataatggaaag-3	 (downstream), MA, USA) according to the manufacturer’s instructions.
were based on a murine cDNA sequence (GenBank,
ImmunocytochemistryAF102269), sharing 90% and 95% homology, respec-
tively, with corresponding rat sequences (GenBank, For demonstration of p65/NF-B nuclear transloca-
U04808). The parameters for rapid cycle DNA amplifi- tion, MCs were incubated with TNF- (5 ng/mL), or ve-
cations were initial denaturation at 94C for three min- hicles for 7.5, 15, or 30 minutes before fixation with 4%
utes, then one second at 94C, one second of annealing paraformaldehyde for one hour at 4C. The cells were
at 55C, and 15 seconds at 72C for 28 cycles (Idaho then washed by 1
 phosphate-buffered saline (PBS)/
Technology), followed by a final extension at 72C for 0.2% TritonX-100 for 15 minutes and incubated with
10 minutes. The amplified products were resolved in 5% rabbit anti-p65/NF-B at 4C overnight. The next day,
polyacrylamide gels. The gels were stained with ethidium after washing for 15 minutes, the cells were incubated
with biotin-conjugated anti-rabbit IgG at room tempera-bromide and photographed.
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ture for one hour. Then, the cells were washed and incu- HPFs were counted per membrane. Similar chemotaxis
bated with the avidin-biotin-peroxidase reagent (Dako- assay was performed with control MC conditioned media
patts, Glostrup, Denmark) at room temperature for one and compared with the results obtained by utilizing
hour. After washing, immunodetection for p65/NF-B TNF-–activated MC conditioned media. A goat anti-
was performed by adding 3-amino-9-ethylcarbazole chro- fractalkine antibody or goat IgG was used in the chemo-
mogen as substrate according to the manufacturer’s in- taxis assay media to determine the biological specificity
structions. of fractalkine produced by MCs to stimulate monocyte
transmigration. Additionally, to demonstrate that J774.A1
Nuclear protein extraction and electrophoretic cells can be attracted by fractalkine, a separate set of
mobility shift analysis (EMSA) experiments was performed in which different concentra-
Nuclear extracts from stimulated or non-stimulated tions of recombinant murine fractalkine in 0.1% RPMI
MCs were prepared by cell lysis followed by nuclear ly- were placed in the lower chamber of Transwell cluster
sis. Briefly, cells were suspended in 30 L of buffer con- plates. After incubation at 37C for four hours, the mono-
taining 10 mmol/L HEPES (pH 7.9), 1.5 mmol/L MgCl2, cytes migrated from the upper chamber were counted
10 mmol/L KCl, 0.5 mmol/L dithiothreitol (DTT), and as described above, and compared to the results obtained
0.2 mmol/L phenylmethylsulfonyl fluoride (PMSF); vig- by utilizing fractalkine-free control media.
orously vortexed for 15 seconds; allowed to stand at 4C
for 10 minutes; and centrifuged at 2000 rpm for two Statistics
minutes. The pelleted nuclei were resuspended in buffer Data are expressed as mean  SEM. All comparisons
containing 20 mmol/L HEPES (pH 7.9), 25% glycerol, were done by analysis of variance (ANOVA) followed
420 mmol/L NaCl, 1.5 mmol/L MgCl2, 0.2 mmol/L ethyl- by Dunnett’s t test using the StatView package for the
enediaminetetraacetic acid (EDTA), 0.5 mmol/L DTT, Macintosh computer (Abacus Concepts, CA, USA). A
and 0.2 mmol/L PMSF for 20 minutes on ice, and then probability value of less than 0.05 was considered statisti-
lysates were centrifuged at 15,000 rpm for two minutes. cally significant.
The supernatants containing the solubilized nuclear pro-
teins were stored at 70C until used for EMSA. The sub-
RESULTSsequent binding reaction was carried out by incubating
15 g of nuclear proteins with 20,000 dpm of 32P-labeled Effects of TNF- on fractalkine mRNA and protein
DNA probe which contained a consensus NF-B recog- expression by MCs
nition element in 20 L of buffer [10 mmol/L Tris pH
Rat MCs were incubated with different concentrations7.5, 1 mmol/L EDTA, 4% Ficoll, 1 mmol/L DTT, 75
of TNF- (0.5 to 50 ng/mL) for varying periods (2 tommol/L KCl, and 0.25 g poly(dI-dC)] for 20 minutes
24 h). The Northern and Western blotting showed thatprior to electrophoresis on a 5% non-denaturing poly-
at basal state MCs expressed a low level of a singleacrylamide gel in a Tris-borate-EDTA buffer system.
species of 3.8 kb fractalkine mRNA and 90 kD cell-Dried gels were exposed to Kodak XR5 film for 4 to 20
bound fractalkine protein. Exogenous TNF- stimulatedhour at70C. Identification of the nuclear proteins that
MC fractalkine mRNA and protein expression in a con-reacted with this probe was obtained by pre-incubating
centration-dependent manner, and the maximal effect ofthe nuclear extracts for five minutes with an antibody
TNF- on MC fractalkine mRNA and protein expression(2.5g) to the p65 subunit of NF-B (Santa Cruz) before
was observed at 24 hours (Fig. 1).a radiolabeled probe was added. EMSA was then per-
formed as outlined and the effect of the antibody on the MC-derived soluble fractalkine
NF-B band examined. is shed from cell-bound fractalkine via
metalloproteinase-dependent cleavageIn vitro chemotaxis assay
Fractalkine has been reported to exist in both a mem-Medium obtained from TNF- (5 ng/mL for 24 h)-
brane-bound and a cleaved soluble form in endothelialactivated MCs were placed in the lower compartment
cells and neurons [4, 5]. Our Western blotting of TNF-–of Transwell cluster plates (Costa Corning) with two
activated MC conditioned media disclosed an approxi-compartment chambers separated by a 5-m polycarbo-
mately 75 kD soluble fractalkine fragment in both time-nate membrane filter. Murine monocyte/macrophages
and dose-dependent manners (Fig. 1B). Because the cell(J774.A1, 5
 104 cells) were added to the upper chamber
lysate of TNF--stimulated MCs also contained a smallerand incubated at 37C for four hours in a humidified 5%
(75 kD) fragment of fractalkine (Fig. 1B), it was un-CO2 incubator. After incubation, the membrane filter
clear whether the soluble fractalkine in the conditionedwas removed, stained with hematoxylin solution and
media was generated within the cells and subsequentlymounted on a glass slide. The migrated monocytes were
secreted, or cleaved and shed from membrane-boundcounted per 
200 high power field (HPF) with the use
of a Nikon UFX-II microscope. Five randomly chosen fractalkine. By using a broad-spectrum zinc-dependent
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Fig. 1. Time-course and dose-response of TNF- stimulation on fractalkine mRNA and protein expression. MCs were incubated with TNF- (0.5
to 50 ng/mL) for the given time period (2 to 24 hours). Ten micrograms of total RNA, 40 g of cell lysate, and 50 g of concentrated condition
media were analyzed for fractalkine mRNA and protein expression as described in the Methods section. (A) Representative Northern blots. Ab-
breviations are: C24, control at 24 hours; FKN, fractalkine mRNA; GAPDH, glyceraldehyde-3-phosphate dehydrogenase mRNA. (B) Representative
Western blots. Abbreviations are: cFKN, cell-bound fractalkine in cell lysate; sFKN, soluble fractalkine in concentrated conditioned media. (C )
The intensity of densitometer readings corrected for GAPDH or -actin, and relative to that of control. Values are mean  SEM of four experi-
ments. *P  0.05 vs. control.
metalloproteinase inhibitor, GM 6001, we showed that the
levels of soluble fractalkine were reduced in association
with a corresponding increase in the amount of cell-bound
fractalkine (Fig. 2). These results suggest that MC-derived
soluble fractalkine was generated mainly from cleavage
of its cell-bound form.
Chemotactic effects of MC-derived soluble fractalkine
on monocyte transmigration in vitro
The monocytes used in the present study, J774.A1
cells, were found to constitutively express mRNA for
CX3CR1 and migrate in response to exogenous murine
fractalkine in a dose-dependent manner (Fig. 3A). Fur-
thermore, TNF- (5 ng/mL for 24 h)-activated MC condi-
tioned media recruited J774.A1 cells about fourfold over
basal control. When the media was preincubated with
different concentrations of an anti-fractalkine neutraliz-
Fig. 2. Effects of GM 6001 on TNF-–stimulated cell-bound and solu- ing antibody for 30 minutes at room temperature, mono-
ble fractalkine expression. MCs were incubated with TNF- (5 ng/mL) cyte migration was attenuated dose-dependently, withfor 24 hours, with or without pretreatment with GM 6001 (2 mol/L) for
a maximal inhibitory effect of approximately 55%. In30 minutes. Upper panel shows representative Western blots. Lanes 1–4,
cFKN in cell lysate; lanes 5–8, sFKN in concentrated conditioned media. contrast, preincubating the media with the same concen-
Lower panel shows quantitative results of cFKN (corrected for -actin) trations of goat IgG did not affect monocyte transmigra-and sFKN relative to that of control. Values are mean  SEM of four
experiments. *P  0.05 vs. control; P  0.05 vs. TNF-–treated cells. tion (Fig. 3B).
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Fig. 3. Cleaved soluble fractalkine in the con-
ditioned media of TNF--activated MCs me-
diates transmigration of J774.A1 cells. (A) Left.
Representative RT-PCR showing constitutive
expression of mRNA for fractalkine receptor
(CX3CR1) in J774.A1 cells, but not rat MC.
Normal rat brain tissue was included as a posi-
tive control. Right. Exogenous murine fractal-
kine dose-dependently increases transmigra-
tion of J774.A1 cells using an in vitro chemotaxis
assay as described in the Methods section. Data
are mean  SEM based on three separate ex-
periments done in duplicate. *P 0.05 vs. con-
trol (C). (B) Effects of the conditioned media
obtained by incubating MCs with TNF- (5
ng/mL) for 24 hours on monocyte transmigra-
tion. Similar studies were performed in the
presence of different concentrations of a goat
anti-fractalkine antibody or goat IgG. Data
are mean  SEM based on three separate
experiments done in duplicate. *P  0.05 vs.
TNF- alone.
Intracellular signaling of TNF-–stimulated MC to explore the regulatory role of PKC isotypes on TNF-–
stimulated fractalkine expression, cells were incubatedfractalkine expression
with an activator of the classical/novel isotype of PKC,By using specific pharmacologic inhibitors, we first eval-
PMA (0.1 mol/L), for four hours. This resulted in an in-uated the role of various protein kinases (PKA, PKC,
crease in fractalkine mRNA expression that could be sup-PI 3-K, p42/44 MAPK, and p38 MAPK) in TNF- stimu-
pressed by calphostin C (400 nmol/L). However, whenlated MC fractalkine expression. The incubation of MCs
MCs were pretreated with PMA (2 mol/L) for 24 hours
with calphostin C (400 nmol/L) or PD98059 (40 mol/L) to deplete classical/novel PKC activity, the subsequent
attenuated MC fractalkine mRNA and protein expres- addition of PMA (0.1 mol/L for 4 h) could not activate
sion driven by TNF- (Fig. 4 A, B). When calphostin C fractalkine gene expression (Fig. 5). In contrast, incuba-
and PD98059 were coincubated with MCs, TNF-–stim- tion of PMA-pretreated cells with TNF- (5 ng/mL) for
ulated fractalkine mRNA and protein expression was four hours still could up-regulate fractalkine mRNA to
inhibited synergistically (Fig. 4C). In contrast, H-89 (2 nearly the same levels as that seen in non-PMA-pre-
mol/L), wortmannin (0.5 mol/L) and SB203580 (40 treated cells. This TNF-–activated fractalkine mRNA
mol/L) did not have discernible effects on TNF-– expression in PMA-pretreated cells could be inhibited
by calphostin C (400 nmol/L; Fig. 5).stimulated fractalkine expression (Fig. 4 A, B). Further,
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Fig. 4. Effects of protein kinase inhibitors on TNF-–stimulated fractalkine mRNA and protein expression. MCs were incubated with TNF- (5
ng/mL) for 4 or 24 hours, with or without pretreatment with the given pharmacologic inhibitor. (A) Upper panel shows representative Northern
blots for H89 (2 mol/L), Cal C (calphostin C 400 nmol/L), PD (PD98059 40 mol/L), SB (SB203580 40 mol/L), and WM (wortmannin 0.5
mol/L). Lower panel shows quantitative results corrected for GAPDH, and relative to that of control. Values are mean SEM of four experiments.
*P  0.05 vs. TNF-–treated cells. (B) Upper panel shows representative Western blots. Lower panel shows quantitative results corrected for -actin,
and relative to that of control. Values are mean  SEM of four experiments. *P  0.05 vs. TNF-–treated cells. (C ) Northern and Western blots
showing that PD98059 and calphostin C synergistically inhibit expression of FKN and cFKN. Results are representative of four separate experiments.
We next incubated the cells with various NF-B inhibi-
tors such as MG132 (10 mol/L), curcumin (40 mol/L),
quercetin (50mol/L), TPCK (25mol/L), and PDTC (50
mol/L) before TNF- stimulation. The results showed
that TNF-–stimulated fractalkine mRNA and protein
expression was completely inhibited (Fig. 6). At the
given concentrations, MG132 and curcumin were able
to block TNF-–induced degradation of I-B, nuclear
translocation of p65/NF-B, and p65/NF-B binding ac-
tivity (Figs. 7C, 8, and 9). However, unlike MG132, cur-
cumin also is known as a c-Jun/AP-1 inhibitor [36, 37].
In this study, we found that curcumin at 20mol/L atten-
panel shows quantitative results of fractalkine/GAPDH mRNA ratios
relative to that of control. Abbreviations are: PMA dep, MCs were
preincubated with PMA (2 mol/L) for 24 hours to deplete endogenous
PKC activity before stimulation with PMA (100 nmol/L) or TNF-
(5 ng/mL) for four hours; Cal C, MCs were pretreated with calphostin C
(400 nmol/L) for one hour before stimulation with PMA or TNF- forFig. 5. Role of PKC in basal and TNF-–stimulated fractalkine mRNA
expression. Upper panel shows representative Northern blots. Lower four hours. Values are mean  SEM of four experiments. *P  0.05.
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Fig. 6. Effects of NF-B inhibitors and curcumin on TNF-–stimulated fractalkine mRNA and protein expression. MCs were pretreated with the
given NF-B inhibitor or curcumin for 1.5 hours, followed by TNF- (5 ng/mL) for 4 or 24 hours. (A) Upper panels show representative Northern
(FKN) and Western (cFKN) blots. Abbreviations and quantities are: MG, MG132 (10 mol/L); Qu, quercetin (50 mol/L); TPCK (25 mol/L);
and PDTC (50 mol/L). Lower panel shows quantitative results of fractalkine/GAPDH mRNA () and cFKN/-actin () ratios relative to that
of control. Values are mean SEM of four experiments. * and denote P 0.05 versus TNF-–treated cells. (B) Upper panel shows representative
Western blots for cFKN. Cu is curcumin (10 to 40 mol/L). Lower panel shows quantitative results of cFKN/-actin ratios relative to that of con-
trol. Values are mean  SEM of four experiments. *P  0.05 vs. TNF-–treated cells.
uated TNF-–activated phospho-c-Jun levels (Fig. 7A), no discernible effect on MC fractalkine mRNA expres-
and partially suppressed TNF-–stimulated fractalkine sion (data not shown). In contrast, the preincubation of
protein expression (Fig. 6B), without affecting degrada- MCs with either cAMP-elevating agent dose-depen-
tion of I-B (Fig. 7C) or nuclear translocation of p65/ dently attenuated TNF-–stimulated fractalkine mRNA
NF-B (data not shown). Neither curcumin nor MG132 and soluble protein expression (Fig. 10). To explore the
affected TNF-–activated phosphorylation of p42/44 underlying mechanisms, MCs were incubated with TNF-
MAPK or PKC/ (Fig. 7 B, D). Additional experiments (5 ng/mL) and db-cAMP (2 mmol/L) for 7.5 to 30 min-
were performed to examine the effects of PD98059 and utes. The results showed that db-cAMP decreased TNF-–
calphostin C on TNF-–activated signaling cascades. Our activated phospho-p42/44 MAPK and phospho-c-Jun
results indicated that PD 98059, but not calphostin C, levels (Fig. 7 A, B), but not degradation of I-B (Fig.
inhibited TNF-–activated phospho-p42/44 MAPK and 7C), phosphorylation of PKC/ (Fig. 7D), or nuclear
phospho-c-Jun levels (Fig. 7 A, B), whereas only calphos- translocation of p65/NF-B (data not shown). Preincuba-
tin C inhibited TNF-–activated phosphorylation of tion of MCs with forskolin also led to a similar down-
PKC/ (Fig. 7D). Neither PD98059 nor calphostin C af- regulation of TNF-–induced phospho-p42/44 MAPK
fected TNF-–induced degradation of I-B (Fig. 7C) and phospho-c-Jun levels, without alterations in I-B
or nuclear translocation of p65/NF-B (Fig. 8). degradation or PKC/ phosphorylation (data not shown).
Effects of cAMP-elevating agents on
DISCUSSIONTNF-–stimulated MC fractalkine expression
This study demonstrated that cultured rat MCs at basalAt the basal state, incubation of MCs with db-cAMP
(2 mmol/L) or forskolin (50 mol/L) for four hours had state expressed a low level of fractalkine mRNA and cell-
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Fig. 7. Western blotting of phospho-c-Jun, phospho-p42/44 MAPK, I-B, and phospho-PKC/ levels stimulated by TNF-; effects of PD98059,
calphostin C, db-cAMP, MG132, and curcumin. MCs were incubated with TNF- (5 ng/mL) for 7.5, 15, and 30 minutes, with or without pretreatment
with the given pharmacologic inhibitor. (A) Representative Western blots detected with an anti-phospho-c-Jun antibody. (B) Representative West-
ern blots detected with an anti-phospho-p42/44 MAPK antibody. (C ) Representative Western blots detected with an anti-I-B antibody. (D)
Representative Western blots detected with an anti-phospho-PKC/ antibody. These experiments were performed three times and similar results
were obtained. Abbreviations are: PD, PD98059 (40 mol/L); Cal C, calphostin C (400 nmol/L); db-cAMP (2 mmol/L); MG, MG132 (10 mol/L);
Cu, curcumin (20 or 40 mol/L).
Fig. 8. Immunostaining of nuclear translocated p65/NF-B induced by TNF-: Effects of MG132, curcumin, PD98059, and calphostin C. (A)
Control. (B) Incubation of MCs with TNF- (5 ng/mL) for 15 min induced nuclear translocation of p65/NF-B. (C and D) curcumin (40 mol/L)
and MG132 (10 mol/L) blocked translocation of p65/NF-B induced by TNF-. (E and F ) PD98059 (40 mol/L) and calphostin C (400 nmol/L)
did not affect TNF-–stimulated nuclear translocation of p65/NF-B (original magnification 
320).
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In contrast, MCs are mesenchymal cells largely pre-
cluded from circulating blood flow. Thus, soluble frac-
talkine generated by MCs may bind to extracellular ma-
trices and form local concentration gradients to attract
leukocytes. This assumption is supported, at least partially,
by the present in vitro chemotaxis assay showing that
the TNF-–activated MC conditioned media increased
monocyte transmigration that could be attenuated, dose-
dependently, by a neutralizing anti-fractalkine antibody.
Together these data suggest that MC-derived soluble
fractalkine is a novel signal for chemoattraction in the
kidney, which may complement the action of endothelial
cell-derived cell-bound fractalkine in the recruitment of
CX3CR1-bearing leukocytes.
Relatively little is known about the mechanism by
which TNF- stimulates fractalkine production by MCs.
The intracellular signaling cascades initiated by TNF-
are complex, including those that activate protein ki-
nases such as PKA, PKC, PI 3-K, p42/44 MAPK, and
p38 MAPK, and transcription factors such as NF-B and
AP-1 [28, 30]. In this study, we showed that TNF-–stim-
ulated MC fractalkine mRNA and protein expression
was attenuated by selective inhibitors of PKC (calphostin
C) and p42/44 MAPK kinase (PD98059), but not PKA
Fig. 9. Inhibition of TNF-–induced NF-B binding activity by MG132 (H-89), PI 3-K (wortmannin), or p38 MAPK (SB203580).
and curcumin. MCs were treated with MG132 (10 mol/L) or curcumin
These results suggest that the cellular signals mediating(40 mol/L) for 1.5 hours prior to the addition of TNF- for 1 hour.
Nuclear extracts were probed for NF-B. In lane 3, extracts were incu- TNF-–stimulated fractalkine expression involve activa-
bated with an antibody to the p65 subunit of NF-B to verify the identify tion of PKC and p42/44 MAPK, rather than PKA, PI
of the TNF-–induced nuclear protein. The supershifted antibody-NF-B
3-K, or p38 MAPK pathways.complexes are indicated by the S arrowhead.
Further evidence supporting that PKC-related mecha-
nism is operating in MC fractalkine gene expression is
based on the results that calphostin C suppressed PMA-
bound protein, which could be up-regulated by TNF- in stimulated fractalkine mRNA expression, and the activa-
both time- and dose-dependent manners. Additionally, tion of PKC-depleted MCs with PMA did not stimulate
the conditioned media of TNF-–activated MCs con- MC fractalkine mRNA expression. These findings speak
tained an approximately 75 kD soluble fractalkine that for the regulatory role of classical and/or novel isotypes
was likely shed from cell-bound fractalkine by metallo- of PKC in phobol ester-sensitive fractalkine expression
proteinase-dependent cleavage, as GM 6001 reduced the in MCs. However, the depletion of (classical/novel) PKC
levels of soluble fractalkine in association with an in- activity by PMA failed to prevent MC fractalkine gene
crease in the amount of cell-bound fractalkine. This find- expression elicited by TNF-, and the degree of TNF-–
ing is consistent with recent observations that cleavage stimulated fractalkine mRNA expression in PMA-pre-
of cell-bound fractalkine, either by matrix metallopro- treated MCs was comparable to that in non-PMA-pre-
teinases or TNF- converting enzyme, is the major source treated cells. These observations raise the possibility that
for soluble fractalkine in cultured endothelial cells [9, 10]. atypical PKCs mediate most, if not all, TNF-–stimulated,
Fractalkine was originally discovered from activated en- PKC-dependent fractalkine gene expression in MCs.
dothelial cells, and its ability to mediate both chemotaxis Nuclear factor-B and AP-1 are key nuclear factors reg-
and adherence of mononuclear cells is unique among the ulating the transactivation of an array of genes involved
chemokine superfamily [4]. However, the idea that frac- in inflammation, cell proliferation, and apoptosis [29, 41,
talkine has chemotactic effects is not generally accepted 42]. The present study has demonstrated that inhibitors
[38]. Recent in vitro studies suggest that endothelial cell- of NF-B (MG132, curcumin, quercetin, TPCK, and PDTC)
derived fractalkine plays a role primarily in leukocyte abolished TNF-–stimulated fractalkine mRNA and pro-
adhesion rather than chemotaxis [39, 40]. In the kidney, tein expression in MCs, indicating that NF-B plays a
it also is possible that soluble fractalkine generated on crucial role in TNF-–stimulated MC fractalkine expres-
the surface of endothelium would be washed away under sion. Our finding is in accord with a recent study finding
that fractalkine induction by inflammatory cytokines ishigh blood flow conditions such as the renal glomerulus.
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Fig. 10. Effects of cAMP-elevating agents on TNF-–stimulated fractalkine mRNA and soluble fractalkine expression. MCs were incubated with
TNF- (5 ng/mL) for 4 or 24 h, with or without pretreatment with (A) db-cAMP (0.2 to 2 mmol/L), or (B) forskolin (25 to 100 mol/L) for 15
and 45 minutes, respectively. Right panels show corresponding quantitative results of fractalkine/GAPDH mRNA ratios () and sFKN () relative
to that of control. Values are mean  SEM of four experiments. * and  denote P  0.05 versus TNF-–treated cells.
NF-B–dependent in rat aortic endothelial cells [27]. gene expression via direct interaction with p65/NF-B
[43]. Thus, PD98059 may act by altering the c-Jun/AP-1Further, we found that the AP-1 inhibitor, curcumin,
partially suppressed TNF-–stimulated MC fractalkine activity to modulate B-dependent fractalkine gene tran-
scription induced by TNF-. In contrast, calphostin Cexpression at a concentration (20 mol/L) that attenu-
ated phospho-c-Jun levels but not nuclear translocation inhibited TNF-–stimulated fractalkine expression at a
concentration that did not affect phosphorylation of p42/of p65/NF-B. This suggests that TNF- also stimulates
fractalkine expression through the c-Jun/AP-1 pathway, 44 MAPK, c-Jun or translocation of p65/NF-B. Calphos-
tin C has been shown to inhibit the atypical PKC activityindependent of NF-B activation. However, our data
that MG132 completely blocked TNF-–stimulated MC induced by IL-1 in MCs [45], and activation of PKC 
has been reported to up-regulate B-dependent tran-fractalkine expression in the presence of augmented lev-
els of phospho-c-Jun argues against such an idea. We scription activity via direct phosphorylation of transacti-
vation domain of p65/NF-B [46]. Accordingly, calphos-surmise that activation of c-Jun/AP-1 is necessary but
not sufficient for TNF-–stimulated fractalkine expres- tin C may act by blocking TNF-–activated atypical PKC
to down-regulate B-dependent fractalkine gene expres-sion. In agreement with this notion, AP-1 proteins have
been shown to interact with p65/NF-B and augment sion. Our results that calphostin C decreased TNF-–
stimulated phospho-PKC/ levels were in accord withits transactivation activity induced by TNF- [43], and
blockade of AP-1 activation by curcumin markedly in- such a notion. We surmise that TNF-–activated p42/44
MAPK and PKC pathways are parallel signals that con-hibits the ability of TNF- to activate B-dependent gene
expression at concentrations that do not inhibit activa- verge in B-dependent fractalkine gene expression. A
schematic diagram for the signaling pathways mediatingtion of NF-B [44].
In our experimental conditions, PD98059 and calphos- TNF-–activated fractalkine expression in cultured MCs
is illustrated in Figure 11.tin C were found to exert differential effects on TNF-–
activated signaling pathways and synergistically inhibit The present study showed that the cAMP-elevating
agents, db-cAMP and forskolin, suppressed TNF-–stim-TNF-–stimulated fractalkine mRNA and protein ex-
pression. We found that PD98059, a selective inhibitor of ulated fractalkine mRNA and soluble protein expression,
preceded by attenuation of phospho-p42/44 MAPK, phos-p42/44 MAPK kinase, inhibited TNF-–stimulated frac-
talkine expression at a concentration that attenuated pho-c-Jun, but not phospho-PKC/ levels, activated by
TNF-. The anti-phospho-p42/44 MAPK effect of thesephospho-c-Jun but not phospho-PKC/ levels, or nuclear
translocation of p65/NF-B. This suggests that mecha- agents closely mimicked the action of PD98059. Indeed,
induction of PKA activity by cAMP has been shown tonisms underlying the inhibitory effect of PD98059 is in-
dependent of the atypical PKC pathway and lies beyond block growth factor-induced raf-1 activity in many cell
types, including the MCs [47, 48]. It is conceivable thatp65/NF-B nuclear translocation. Among those, AP-1
proteins have been shown to mediate TNF-–activated these cAMP-elevating agents may act through antago-
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kine expression. Uncoupling of p42/44 MAPK or c-Jun/
AP-1 signals may contribute to cAMP inhibition of MC
fractalkine production stimulated by TNF-.
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